- Home
- SEVN vs TARA Comparison
SEVN vs TARA Comparison
Compare SEVN & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEVN | TARA |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.9M | 159.6M |
| IPO Year | 2008 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SEVN | TARA |
|---|---|---|
| Price | $6.93 | $2.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | $9.55 | ★ $25.71 |
| AVG Volume (30 Days) | 163.8K | ★ 1.3M |
| Earning Date | 10-27-2026 | 11-09-2026 |
| Dividend Yield | ★ 16.18% | N/A |
| EPS Growth | N/A | ★ 38.25 |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $29,383,000.00 | $2,948,000.00 |
| Revenue This Year | $18.67 | N/A |
| Revenue Next Year | $12.98 | N/A |
| P/E Ratio | $36.42 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.70 | $2.51 |
| 52 Week High | $10.90 | $7.82 |
Technical Indicators
Market Signals| Indicator | SEVN | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 36.63 | 28.82 |
| Support Level | N/A | N/A |
| Resistance Level | $7.84 | $4.13 |
| Average True Range (ATR) | 0.17 | 0.21 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 26.45 | 16.71 |
Price Performance
Historical ComparisonAbout SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in originating and investing in floating-rate first mortgage loans secured by middle-market and transitional commercial real estate. Its primary objective is to balance capital preservation with the generation of risk-adjusted returns. The company operates in one business segment: originating and investing in floating-rate first mortgage loans secured by CRE properties.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.